glp 1 agonist vs metformin GLP-1 vs. Metformin: Adherence in PCOS Treatment - Oana Disproportionality analysis of GLP-1 receptor
Description
For people who stopped taking GLP-1 weight-loss medications, patients regained about 60% of the weight []
For humans, the model-predicted median clearance (CL) and volume of distribution (Vss) of semaglutide were 0.0397 L/h and 6.23 L, respectively
Methods A systematic review was conducted following PRISMA 2020 guidelines (PROSPERO: CRD420261305875)
Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov
Visit Us!
